Milestone Pharmaceuticals (MIST) vs Telomir Pharmaceuticals (TELO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Telomir Pharmaceuticals (TELO) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 30.3% versus a loss of 64.4%. Milestone Pharmaceuticals is the larger company by market cap ($88.7 million vs $84.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MIST | TELO |
|---|---|---|
| Share price | $0.7121 | $1.15 |
| Market cap | $88.66M | $84.66M |
| 1-day change | -5.96% | +2.68% |
| YTD return | -64.75% | -13.53% |
| 1-year return | -64.39% | -30.30% |
| 5-year return | -87.93% | — |
| EPS (TTM) | $-0.68 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.06 | $2.09 |
| 52-week low | $0.7096 | $0.888 |
| Distance from 52-week high | -76.73% | -45.00% |
| Analyst consensus | none | none |
| Avg. price target upside | +722.92% | +247.83% |
| Average volume | 1.39M | 97.37K |
| Shares outstanding | 124.50M | 73.62M |
| Employees | 38 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TELO has outperformed MIST by 34.1 percentage points over the past year.
About Milestone Pharmaceuticals
MIST stock →Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.
Healthcare · Biotechnology · 38 employees
About Telomir Pharmaceuticals
TELO stock →Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria.
Healthcare · Biotechnology
MIST vs TELO FAQ
Which is bigger, Milestone Pharmaceuticals or Telomir Pharmaceuticals?
Milestone Pharmaceuticals (MIST) is larger, with a market capitalization of $88.66M compared with $84.66M for Telomir Pharmaceuticals (TELO).
Which stock has performed better over the past year, MIST or TELO?
TELO returned -30.30% over the past 12 months, compared with -64.39% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Pharmaceuticals and Telomir Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.